News Hub

Real-time financial, economic, and global news with market-focused context and analysis.

Coverage spans equities, macroeconomic data, commodities, currencies, technology, politics, and global events—paired with analysis that highlights why each development matters for traders and investors. From breaking headlines to hourly market snapshots and in-depth articles, the News Hub is designed to help you stay informed, oriented, and ahead of market-moving events.

  • About 2,000 Brazilian export product categories will be exempted from newly implemented U.S. tariffs.
  • Brazilian coffee and orange juice exporters received full exemptions from the new U.S. tariffs.
  • The U.S. policy creates a tiered tariff system separating single-levy and dual-levy sectors.
  • Exemptions will limit immediate tariff costs for affected Brazilian exporters.
  • ASX Chief Financial Officer Andrew Tobin announced his retirement.
  • Euronext executive Anthony Attia has been confirmed as ASX's incoming CEO.
  • The exchange remains under heightened regulatory scrutiny following 2025 operational incidents.

Latest Articles

Circle (CRCL) - Tactical Swing Setup as USDC Monetization Starts to Land

Circle (CRCL) - Tactical Swing Setup as USDC Monetization Starts to Land

Circle’s operating story is moving from promise to predictable cash flows: protocol fee streams, institutional integrations and recent partner deals are starting to show up in the numbers. The market has priced growth ambitions into a high multiple, but several near-term catalysts could re-rate the stock. We outline a tactical long swing with defin…

Universal Music's Board Rejects Pershing Square Offer

Universal Music's Board Rejects Pershing Square Offer

Universal Music Group’s board has turned down an unsolicited cash-and-stock takeover proposal from Bill Ackman’s Pershing Square, concluding the bid undervalues the company and would not create superior value for stakeholders. Pershing Square had earlier valued UMG at about €30.40 per share in a transaction worth roughly €55.75 billion. UMG is expe…

USANA Health Sciences Executive Sells Shares Amid Quarterly Earnings Beat

USANA Health Sciences Executive Sells Shares Amid Quarterly Earnings Beat

Paul A. Jones, Chief People Officer at USANA Health Sciences Inc., recently sold a portion of his common stock holdings in the company. This transaction occurs against a backdrop of positive corporate activity, including robust first-quarter financial results that surpassed analyst expectations and a recent annual shareholders' meeting where board …

Zelenskiy: Intelligence Indicates Russia Is Preparing Large-Scale Strike on Ukraine

Zelenskiy: Intelligence Indicates Russia Is Preparing Large-Scale Strike on Ukraine

Ukrainian President Volodymyr Zelenskiy said intelligence shows Russia is preparing a new large-scale attack. He said Ukrainian air forces and air defenders are on constant alert and urged partners to accelerate agreed air-defence measures while calling for additional sanctions. Russia has warned of systematic strikes on Kyiv and cited a deadly dor…

ICE Agent Arrested in Texas After State Charges Over Minneapolis Shooting

ICE Agent Arrested in Texas After State Charges Over Minneapolis Shooting

A U.S. Immigration and Customs Enforcement (ICE) agent, Christian Castro, was taken into custody in Texas after Minnesota prosecutors charged him with shooting a Venezuelan man in Minneapolis on January 14. The arrest follows a state investigation that located Castro in Texas and involved Texas Rangers and agents from the Department of Homeland Sec…

Visa - Buy for Durable Cash Flow and Growing Dividends

Visa - Buy for Durable Cash Flow and Growing Dividends

Visa (V) combines a highly profitable payments franchise with strong free cash flow and a track record of rising payouts. At ~$330, the stock is not cheap by traditional multiples, but its 51% ROE, $21.2B in free cash flow, low net leverage and room to expand digital rails make it a pragmatic buy for long-term dividend growth. Trade plan enclosed w…

Cellebrite Shares Jump After DA Davidson Buy Call and Strong Q1 Results

Cellebrite Shares Jump After DA Davidson Buy Call and Strong Q1 Results

Cellebrite DI stock rallied more than 8% in mid-day trade after DA Davidson started coverage with a Buy rating and a $20 price target. The broker highlighted an understated and expanding total addressable market and potential for continued wallet share gains and accelerated ARR growth. That analyst catalyst arrived on the heels of first-quarter out…

Macquarie Moves Li Auto to Neutral as Early Signs of Recovery Emerge

Macquarie Moves Li Auto to Neutral as Early Signs of Recovery Emerge

Macquarie upgraded Li Auto to Neutral from Underperform in a May 29 research note, saying the Chinese EV maker’s first-quarter 2026 results likely represent the weakest quarter of the year. The brokerage pointed to narrowing downside risks from large cash reserves, a US$1 billion buyback, and upcoming model launches, even as margins, revenue and de…

Cuprina Holdings Announces Completion of Reverse Stock Split and Requests a Hearing before the Nasdaq Hearings Panel to Maintain Listing

Cuprina Holdings Announces Completion of Reverse Stock Split and Requests a Hearing before the Nasdaq Hearings Panel to Maintain Listing

Cuprina Holdings completed a reverse stock split to increase its share price and requested a hearing before the Nasdaq Hearings Panel to appeal a delisting decision after failing to meet Nasdaq's minimum bid price requirement. The company aims to maintain its listing on The Nasdaq Capital Market amid ongoing compliance challenges.

J&J Unit Abiomed Cleared in Massachusetts Patent Trial Over Impella Heart Pump

J&J Unit Abiomed Cleared in Massachusetts Patent Trial Over Impella Heart Pump

A jury in Massachusetts ruled that Abiomed’s Impella intravascular heart pumps do not infringe a patent held by Maquet Cardiovascular and also found the patent invalid. The decision follows a 2017 lawsuit and comes after Johnson & Johnson’s 2022 acquisition of Abiomed. The verdict was described by a J&J spokesperson as vindication of Abiomed’s inno…

MannKind Announces FDA Approval of Afrezza®, the First and Only Inhaled Mealtime Insulin for Use in Children and Adolescents Aged 6 and Older Living with Diabetes

MannKind Announces FDA Approval of Afrezza®, the First and Only Inhaled Mealtime Insulin for Use in Children and Adolescents Aged 6 and Older Living with Diabetes

MannKind Corporation announced FDA approval for Afrezza, the first inhaled mealtime insulin for children aged 6 and older with type 1 and type 2 diabetes. This approval provides a novel, needle-free insulin option that offers rapid onset and dosing flexibility, potentially improving glycemic control and quality of life for pediatric patients and th…

ATN International, Inc. to Present and Host 1x1 Investor Meetings at the 16th Annual East Coast IDEAS Investor Conference on June 11, 2026 in New York

ATN International, Inc. to Present and Host 1x1 Investor Meetings at the 16th Annual East Coast IDEAS Investor Conference on June 11, 2026 in New York

ATN International, a leading digital infrastructure and communications services provider, announced its participation in the 16th Annual East Coast IDEAS Investor Conference on June 11, 2026. The company will host one-on-one investor meetings and a live webcast presentation, highlighting its focus on rural and remote markets in the U.S. and Caribbe…

Putin Says Origin of Drone That Fell in Romania Cannot Yet Be Determined

Putin Says Origin of Drone That Fell in Romania Cannot Yet Be Determined

Russian President Vladimir Putin said it was premature to conclude whether the drone that crashed into an apartment block in Romania was Russian, suggesting it could have been Ukrainian and calling for forensic analysis. NATO has accused Moscow of reckless behaviour and vowed to defend allied territory after Romania said a Russian drone had struck …